Published in Health Qual Life Outcomes on April 11, 2003
Web-based Education to Enhance Fibromyalgia Management | NCT00423631
The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med (2009) 2.18
The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes (2008) 2.07
Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study. Neurology (2011) 1.89
Therapeutic bronchoscopy for malignant central airway obstruction: success rates and impact on dyspnea and quality of life. Chest (2015) 1.80
The societal and economic value of rotator cuff repair. J Bone Joint Surg Am (2013) 1.73
Effects of mode and order of administration on generic health-related quality of life scores. Value Health (2009) 1.72
Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin Proc (2010) 1.62
Health status in young adults two decades after pediatric liver transplantation. Am J Transplant (2012) 1.54
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax (2009) 1.46
Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res (2011) 1.43
Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope (2011) 1.34
Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries. Health Qual Life Outcomes (2013) 1.26
Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health Qual Life Outcomes (2009) 1.16
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transplant (2015) 1.12
Health-related quality of life (EQ-5D) before and after orthopedic surgery. Acta Orthop (2010) 1.11
Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual Life Outcomes (2006) 1.10
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci (2012) 1.07
The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. Respir Med (2012) 1.04
'PhysioDirect' telephone assessment and advice services for physiotherapy: protocol for a pragmatic randomised controlled trial. BMC Health Serv Res (2009) 1.04
How bad is depression? Preference score estimates from depressed patients and the general population. Health Serv Res (2009) 1.01
Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial. J Gen Intern Med (2012) 1.00
Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey. Health Qual Life Outcomes (2012) 0.99
Health related quality of life outcome instruments. Eur Spine J (2005) 0.98
Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients. Med Decis Making (2011) 0.97
Standard error of measurement of 5 health utility indexes across the range of health for use in estimating reliability and responsiveness. Med Decis Making (2010) 0.96
Associations of cancer and other chronic medical conditions with SF-6D preference-based scores in Medicare beneficiaries. Qual Life Res (2013) 0.95
Long-term utility outcomes in patients undergoing endoscopic sinus surgery. Laryngoscope (2013) 0.91
Cigarette smoking and health-related quality of life in Medicare beneficiaries. Health Care Financ Rev (2008) 0.91
The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure. Eur J Health Econ (2010) 0.91
Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores. Med Care (2011) 0.90
Health-related quality of life changes associated with buprenorphine treatment for opioid dependence. Qual Life Res (2011) 0.89
Race and preference-based health-related quality of life measures in the United States. Qual Life Res (2010) 0.89
Health utility outcomes in patients undergoing medical management for chronic rhinosinusitis: a prospective multiinstitutional study. Int Forum Allergy Rhinol (2015) 0.88
Responsiveness of the electronic Personal Assessment Questionnaire-Pelvic Floor (ePAQ-PF). Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.88
Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36. Value Health (2009) 0.87
Cost-utility analysis of posterior minimally invasive fusion compared with conventional open fusion for lumbar spondylolisthesis. SAS J (2011) 0.87
Comparison and correlates of three preference-based health-related quality-of-life measures among overweight and obese women with urinary incontinence. Qual Life Res (2011) 0.85
Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction (2011) 0.85
Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom. Clin Exp Gastroenterol (2012) 0.84
Three methods tested to model SF-6D health utilities for health states involving comorbidity/co-occurring conditions. J Clin Epidemiol (2009) 0.83
Relationship of meeting physical activity guidelines with quality-adjusted life-years. Semin Arthritis Rheum (2014) 0.83
Burden of peripheral arterial disease in Europe and the United States: a patient survey. Health Qual Life Outcomes (2013) 0.82
Do medical house officers value the health of veterans differently from the health of non-veterans? Health Qual Life Outcomes (2004) 0.82
Population norms and cut-off-points for suboptimal health related quality of life in two generic measures for adolescents: the Spanish VSP-A and KINDL-R. Health Qual Life Outcomes (2009) 0.82
Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom. Int J Womens Health (2013) 0.81
A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). PLoS One (2014) 0.80
Using QALYs in telehealth evaluations: a systematic review of methodology and transparency. BMC Health Serv Res (2014) 0.80
Minimal clinically important difference on the Beck Depression Inventory - II according to the patient's perspective. Psychol Med (2015) 0.80
Health-related quality of life in persons with apparent treatment-resistant hypertension on at least four antihypertensives. J Hum Hypertens (2015) 0.80
The incremental burden of pain in patients with depression: results of a Japanese survey. BMC Psychiatry (2015) 0.80
Realising the potential of the family history in risk assessment and primary prevention of coronary heart disease in primary care: ADDFAM study protocol. BMC Health Serv Res (2009) 0.80
Impact of middle-of-the-night awakenings on health status, activity impairment, and costs. Nat Sci Sleep (2014) 0.80
Increased number of structured diabetes education attendance was not associated with the improvement in patient-reported health-related quality of life: results from Patient Empowerment Programme (PEP). Health Qual Life Outcomes (2015) 0.79
Comparison of general population, patient, and carer utility values for dementia health states. Med Decis Making (2014) 0.79
Minimal clinically important differences in the brief pain inventory in patients with bone metastases. Support Care Cancer (2013) 0.79
Estimating the Impact of Workplace Bullying: Humanistic and Economic Burden among Workers with Chronic Medical Conditions. Biomed Res Int (2015) 0.79
Assessing the impact of dietary habits on health-related quality of life requires contextual measurement tools. Front Pharmacol (2015) 0.79
Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer. BMC Gastroenterol (2015) 0.79
Physical violence and health-related quality of life: Danish cross-sectional analyses. Health Qual Life Outcomes (2012) 0.78
A comparison of four different HRQoL generic questionnaire in five different patient groups. Rheumatol Int (2009) 0.77
The Patient-Oriented Eczema Measure in young children: responsiveness and minimal clinically important difference. Allergy (2016) 0.77
Impact of disability on different domains of health-related quality of life in the noninstitutionalized general population. Clinicoecon Outcomes Res (2010) 0.77
The Association between Insomnia and Insomnia Treatment Side Effects on Health Status, Work Productivity, and Healthcare Resource Use. PLoS One (2015) 0.76
Do modern total knee replacements offer better value for money? A health economic analysis. Int Orthop (2013) 0.76
The effect of weight loss on changes in health-related quality of life among overweight and obese women with urinary incontinence. Qual Life Res (2011) 0.76
The self-reported Physical Activity Scale for the Elderly (PASE) is a valid and clinically applicable measure in lung cancer. Support Care Cancer (2015) 0.76
Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism. Appl Health Econ Health Policy (2015) 0.76
Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study. Health Qual Life Outcomes (2012) 0.75
Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey. Neuropsychiatr Dis Treat (2015) 0.75
Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis. Value Health (2016) 0.75
Is exposure in vivo cost-effective for chronic low back pain? A trial-based economic evaluation. BMC Health Serv Res (2015) 0.75
Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of early phase I cardiac rehabilitation. Health Qual Life Outcomes (2017) 0.75
The minimal important difference of the pulmonary functional status and dyspnea questionnaire in patients with severe chronic obstructive pulmonary disease. Respir Res (2013) 0.75
Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association? J Rheumatol (2016) 0.75
How is the most severe health state being valued by the general population? Health Qual Life Outcomes (2014) 0.75
Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey. Health Qual Life Outcomes (2012) 0.75
Review article: outcomes in endoscopic sinus surgery. BMC Ear Nose Throat Disord (2016) 0.75
The relationship between pain severity and patient-reported outcomes among patients with chronic low back pain in Japan. J Pain Res (2016) 0.75
Health utility values for patients with recurrent acute rhinosinusitis undergoing endoscopic sinus surgery: a nested case control study. Int Forum Allergy Rhinol (2016) 0.75
Perceived cognitive deficits are associated with diabetes self-management in a multiethnic sample. J Diabetes Metab Disord (2017) 0.75
A health economic model for the development and evaluation of innovations in aged care: an application to consumer-directed care-study protocol. BMJ Open (2014) 0.75
Chronic stable angina is associated with lower health-related quality of life: evidence from Chinese patients. PLoS One (2014) 0.75
The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya. Health Qual Life Outcomes (2017) 0.75
Depression severity and concentration difficulties are independently associated with HRQOL in patients with unipolar depressive disorders. Qual Life Res (2017) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol (1991) 22.01
Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials (1989) 15.99
Effect sizes for interpreting changes in health status. Med Care (1989) 15.39
The estimation of a preference-based measure of health from the SF-36. J Health Econ (2002) 14.18
Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol (1994) 9.50
Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis (1987) 9.25
Methods to explain the clinical significance of health status measures. Mayo Clin Proc (2002) 7.00
The RAND-36 measure of health-related quality of life. Ann Med (2001) 5.26
Comparisons of five health status instruments for orthopedic evaluation. Med Care (1990) 4.57
Cost effectiveness of community leg ulcer clinics: randomised controlled trial. BMJ (1998) 4.10
Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol (1998) 3.57
Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care (1999) 3.57
Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol (1997) 3.14
Introducing economic and quality of life measurements into clinical studies. Ann Med (2001) 2.99
Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum (1985) 2.85
Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford) (1999) 2.51
Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care (2001) 2.36
Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax (1997) 2.32
Using the SF-36 with older adults: a cross-sectional community-based survey. Age Ageing (2001) 2.21
Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc (2002) 1.93
Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics (2002) 1.44
Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc (2002) 1.44
Assessing meaningful change in quality of life over time: a users' guide for clinicians. Mayo Clin Proc (2002) 1.43
Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire. Qual Life Res (2002) 1.39
Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clin Proc (2002) 1.37
Use of the reliable change index to evaluate clinical significance in SF-36 outcomes. Qual Life Res (2002) 1.21
Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clin Proc (2002) 1.09
The clinical significance of quality-of-life results: practical considerations for specific audiences. Mayo Clin Proc (2002) 1.05
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res (2005) 6.25
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med (2005) 2.07
The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci (2005) 1.91
Cost effectiveness of a community based exercise programme in over 65 year olds: cluster randomised trial. J Epidemiol Community Health (2004) 1.63
Improving the measurement of QALYs in dementia: developing patient- and carer-reported health state classification systems using Rasch analysis. Value Health (2011) 1.52
Estimating a preference-based index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): valuation of CORE-6D. Med Decis Making (2012) 1.51
Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey. Health Econ (2006) 1.49
Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics (2002) 1.44
Modelling SF-6D health state preference data using a nonparametric Bayesian method. J Health Econ (2006) 1.40
A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care (2004) 1.27
Mapping onto Eq-5 D for patients in poor health. Health Qual Life Outcomes (2010) 1.20
An assessment of the construct validity of the ASCOT measure of social care-related quality of life with older people. Health Qual Life Outcomes (2012) 1.18
The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis. Qual Life Res (2008) 1.14
Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire. Med Decis Making (2010) 1.09
Populating an economic model with health state utility values: moving toward better practice. Value Health (2010) 1.09
Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res (2005) 1.08
Best-worst scaling vs. discrete choice experiments: an empirical comparison using social care data. Soc Sci Med (2011) 1.07
Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses. Health Qual Life Outcomes (2008) 0.98
Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems (CORE-OM). Qual Life Res (2010) 0.97
Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. Value Health (2004) 0.96
The use of rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D. Med Decis Making (2010) 0.96
Developing preference-based health measures: using Rasch analysis to generate health state values. Qual Life Res (2010) 0.96
Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy. Value Health (2012) 0.95
US valuation of the SF-6D. Med Decis Making (2013) 0.94
The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Qual Life Res (2008) 0.94
Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation. Qual Life Res (2011) 0.92
Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available. Value Health (2011) 0.91
Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method. Soc Sci Med (2006) 0.88
A randomised controlled trial and cost-effectiveness evaluation of "booster" interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods. BMC Public Health (2010) 0.87
A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method. Stat Med (2010) 0.85
Impact of intravenous drug use on quality of life for patients with venous ulcers. J Adv Nurs (2007) 0.82
Health state utilities for skeletal-related events secondary to bone metastases. Eur J Health Econ (2013) 0.82
Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample. Eur J Health Econ (2014) 0.82
Modeling SF-6D Hong Kong standard gamble health state preference data using a nonparametric Bayesian method. Value Health (2013) 0.81
A comparison of the discriminative and evaluative properties of the SF-36 and the SF-6D index. Qual Life Res (2011) 0.81
Estimating the SF-6D value set for a population-based sample of Brazilians. Value Health (2011) 0.80
Utility scores for the Health Utilities Index Mark 2: an empirical assessment of alternative mapping functions. Med Care (2005) 0.80
The development of a QALY measure for epilepsy: NEWQOL-6D. Epilepsy Behav (2012) 0.78
Clustering Rasch results: a novel method for developing rheumatoid arthritis states for use in valuation studies. Value Health (2010) 0.78
Do Portuguese and UK health state values differ across valuation methods? Qual Life Res (2011) 0.77
Predicting preference-based utility values using partial proportional odds models. BMC Res Notes (2014) 0.77
A systematic review of health-related quality of life instruments used for people with venous ulcers: an assessment of their suitability and psychometric properties. J Clin Nurs (2010) 0.77
Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes. Value Health (2011) 0.76
Impact of discussion on preferences elicited in a group setting. Health Qual Life Outcomes (2006) 0.75
Using mixed methods research to explore the effect of an adaptation exercise on general population valuations of health states. Qual Life Res (2011) 0.75
Exploring the consistency of the SF-6D. Value Health (2013) 0.75
Assessing current health-related quality of life questionnaires administered to patients with venous ulcers: can they be used in economic evaluations? J Clin Nurs (2010) 0.75